AVITA Medical, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
66.51 |
98.29 |
134.25 |
175.03 |
401.67 |
525.23 |
| Przychód Δ r/r |
0.00% |
47.77% |
36.59% |
30.37% |
129.49% |
30.76% |
| Przychód (min) |
59.88 |
88.48 |
111.71 |
173.48 |
361.61 |
472.84 |
| Przychód (max) |
77.07 |
113.89 |
175.85 |
176.58 |
465.44 |
608.62 |
| EBITDA (średnia) |
-53.61 |
-79.22 |
-108.20 |
-141.07 |
-323.74 |
-423.33 |
| EBIT (średnia) |
-54.67 |
-80.78 |
-110.33 |
-143.85 |
-330.12 |
-431.67 |
| EBIT % |
-82.19% |
-82.19% |
-82.19% |
-82.19% |
-82.19% |
-82.19% |
| Zysk netto (średni) |
-90.13 |
-87.73 |
5.76 |
38.81 |
197.55 |
251.62 |
| Zysk netto % |
-135.51% |
-89.26% |
4.29% |
22.17% |
49.18% |
47.91% |
| EPS (średnia) |
-3.56 |
-3.39 |
-0.68 |
2.01 |
7.63 |
9.72 |
| Liczba analityków (Przychody) |
6 |
5 |
9 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
6 |
5 |
6 |
3 |
1 |
1 |
| symbol |
RCEL |
RCEL |
RCEL |
RCEL |
RCEL |
RCEL |